NASDAQ: KALAKala Bio Inc Stock Ownership - Who owns Kala Bio?
Insider buying vs selling
Have Kala Bio Inc insiders been buying or selling?
Buy
Sell
| Name | Role | Date | Shares | Price | Value |
|---|---|---|---|---|---|
| Mark T. Iwicki | Director | 2025-10-23 | 154,894 | $0.81 | $125.46kSell |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 2025-10-23 | 967 | $0.82 | $792.94Sell |
| Romulus K. Brazzell | Head of Research and Development and Chief Medical Officer | 2025-10-22 | 46,748 | $0.83 | $38.80kSell |
| Todd Bazemore | Director | 2025-10-22 | 47,768 | $0.83 | $39.65kSell |
| Darius Kharabi | CHIEF BUSINESS OFFICER | 2025-10-22 | 20,806 | $0.83 | $17.27kSell |
| Mary Reumuth | CHIEF FINANCIAL OFFICER | 2025-10-22 | 32,230 | $0.83 | $26.75kSell |
| Baker Bros Advisors LP | Insider | 2025-10-01 | 50,640 | $1.38 | $70.09kSell |
| Baker Bros Advisors LP | Insider | 2025-10-01 | 462,967 | $1.38 | $640.75kSell |
| Baker Bros Advisors LP | Insider | 2025-09-30 | 195,425 | $1.60 | $311.90kSell |
| Baker Bros Advisors LP | Insider | 2025-09-30 | 21,376 | $1.60 | $34.12kSell |
KALA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership
Be the first to know when KALA insiders and whales buy or sell their stock.
KALA Shareholders
What type of owners hold Kala Bio Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Rajeev M. Shah | 117.21% | 21,789,226 | $25.60M | Insider |
| Ra Capital Management LP | 94.86% | 17,634,380 | $20.72M | Insider |
| Gregory Grunberg | 29.33% | 5,451,860 | $6.41M | Insider |
| Orbimed Advisors LLC | 18.55% | 3,447,840 | $4.05M | Insider |
| Oxford Finance LLC | 8.71% | 1,620,000 | $1.90M | Insider |
| Baker Bros Advisors LP | 2.29% | 425,006 | $499.38k | Insider |
| Renaissance Technologies LLC | 2.25% | 417,517 | $490.58k | Institution |
| Citadel Advisors LLC | 1.52% | 281,650 | $330.94k | Institution |
| Geode Capital Management LLC | 1.40% | 261,061 | $306.75k | Institution |
| Hongming Chen | 1.10% | 204,515 | $240.31k | Insider |
KALA vs Pharmaceutical Stocks
Kala Bio Stock Ownership FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.